Büchi Labortechnik

Vaccines: Discovery & Development, Cologne, Germany

Tuesday, December 04, 2007 - Wednesday, December 05, 2007

Print Email to a friend

Vaccines: Discovery and Development presents advances in enhancing immunogenicity including the latest developments in adjuvants, vectors, delivery, formulation, t-cell epitope modification and, for cancer vaccines, the breaking of tolerance.

Based on in-depth research with leaders in the field along with potential delegates, Vaccines: Discovery and Development brings together over 31 industry expert speakers presenting 27 case studies to reveal how you can achieve the full potential of your vaccines.

Key reasons to attend:


  • Discover the latest thinking on immunological mechanisms behind vaccines and adjuvants

  • Learn about recent developments with adjuvants including TLR agonists, MF39 and cationic liposome adjuvants

  • Analyse the real advances in transcutaneous immunisation

  • Review cutting-edge characterisation technologies

  • Industry experts will reveal what they have discovered in their efforts to stimulate the immune response and overcome tolerance for therapeutic vaccines

  • Find out the latest developments in proof of concept and immune correlates for therapeutic vaccines

Further Information: http://www.iir-events.com/IIR-Conf/page.aspx?id=9522